Sectors
HROW
Harrow Health, Inc.
43.68
3 x 43.73
1 x 43.81
bid
ask
-
0.03
0.07%
01:53 PM
timesize
| Ytd | -10.86% | |
| 1y | 20.96% |
42.62
day range
43.99
28.54
52 week range
54.85
| Open | 43.99 | Prev Close | 43.71 | Low | 42.62 | High | 43.99 | Mkt Cap | 1.63B |
| Vol | 157.44K | Avg Vol | 829.73K | EPS | 0.09 | P/E | 485.67 | Forward P/E | 277.78 |
| Beta | 0.26 | Short Ratio | 9.13 | Inst. Own | 58.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 38.22 | 200-d Avg | 41.20 | 1yr Est | 67.75 |
| Income Statement | |||
| Total Revenue | 44.20M | ||
| Revenues (USD) | 44.20M | ||
| Cost of Revenue | 17.16M | ||
| Gross Profit | 27.05M | ||
| Operating Expenses | 49.13M | ||
| Research and Development Expense | 5.90M | ||
| Selling, General and Administrative Expense | 43.23M | ||
| Operating Income | -22.08M | ||
| Interest Expense | 5.50M | ||
| Income Tax Expense | 25.00K | ||
| Net Income | -27.60M | ||
| Net Income Common Stock | -27.60M | ||
| Net Income Common Stock (USD) | -27.60M | ||
| Consolidated Income | -27.60M | ||
| Earnings per Basic Share | -0.74 | ||
| Earnings per Basic Share (USD) | -0.74 | ||
| Earnings per Diluted Share | -0.74 | ||
| Earning Before Interest & Taxes (EBIT) | -22.08M | ||
| Earning Before Interest & Taxes (USD) | -22.08M | ||
| Weighted Average Shares | 37.23M | ||
| Weighted Average Shares Diluted | 37.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 94.64M | ||
| Cash and Equivalents (USD) | 94.64M | ||
| Trade and Non-Trade Receivables | 101.26M | ||
| Current Assets | 226.38M | ||
| Property, Plant & Equipment Net | 10.72M | ||
| Total Assets | 419.54M | ||
| Debt Current | 915.00K | ||
| Total Debt | 300.67M | ||
| Current Liabilities | 91.44M | ||
| Debt Non-Current | 299.75M | ||
| Total Liabilities | 391.19M | ||
| Accumulated Retained Earnings (Deficit) | -184.13M | ||
| Shareholders Equity | 28.71M | ||
| Shareholders Equity (USD) | 28.71M | ||
| Assets Non-Current | 193.16M | ||
| Total Debt (USD) | 300.67M | ||
| Deferred Revenue | 149.00K | ||
| Goodwill and Intangible Assets | 182.44M | ||
| Inventory | 16.50M | ||
| Liabilities Non-Current | 299.75M | ||
| Trade and Non-Trade Payables | 30.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.78M | ||
| Net Cash Flow from Financing | 48.91M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 21.72M | ||
| Capital Expenditure | -194.00K | ||
| Issuance (Purchase) of Equity Shares | 25.00K | ||
| Issuance (Repayment) of Debt Securities | 48.89M | ||
| Net Cash Flow from Investing | -18.20M | ||
| Net Cash Flow from Operations | -8.99M | ||
| Share Based Compensation | 3.84M | ||